Global Expansion Encube Ethicals has secured significant funding of over 110 million USD and formed strategic partnerships with notable players like Quadria Capital and Lodha Group, positioning itself for substantial international growth and market entry opportunities.

Innovative R&D With a dedicated R&D center housing over 150 scientists focused on topical formulations, Encube presents opportunities to collaborate on new product development and advance formulation technologies for prescription and OTC markets.

Strong Market Presence As the world’s largest single-site topical manufacturing facility, Encube offers a robust manufacturing platform that can support large-scale supply chain partnerships and fulfill expanding global demand for topical pharmaceutical products.

Customer Segments Encube's focus on topical prescription, OTC, and cosmetic formulations indicates potential sales channels in pharmaceuticals, beauty, and skincare sectors, appealing to clients seeking specialized contract manufacturing services.

Technological Capabilities Utilizing advanced tech stacks and maintaining high standards in manufacturing and R&D, Encube is well-positioned to attract clients seeking reliable, innovative, and secure production of sensitive topical formulations.